Skip to content

Use of Vasadi Kwatha Sharkara in the Management of Bronchial Asthma in children

CLINICAL STUDY ON VASADI KWATHA SHARKARA IN THE MANAGEMENT OF TAMAKA SHWASA (BRONCHIAL ASTHMA) IN CHILDREN

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/033236
Enrollment
40
Registered
2021-04-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

Intervention1: Vasadi Kwatha Sharkara: Dose-1ml/kg body weight/day. Frequency- thrice in a day. Mode of administration- oral. Control Intervention1: Nil: Nil

Sponsors

DSRRAU Karwar Jodhpur Rajasthan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children age group from 05-12 years of either sex having clinical signs & symptoms of Tamaka Shwasa 2. Pre diagnosed and confirmed patients of Tamaka Shwasa.

Exclusion criteria

Exclusion criteria: 1.Child below 05 year & above 12 years of age will be excluded from present study. 2.Patients suffering from chronic respiratory disorders like pulmonary tuberculosis, chronic lung disease, pulmonary edema, branchiogenic carcinoma will be excluded from present study. 3.Patient suffering from cardiac disease, GIT disease, genitourinary disease, metabolic disorders like diabetes mellitus and behavioral disorders etc. will be excluded from study.

Design outcomes

Primary

MeasureTime frame
Relief in signs and symptomsTimepoint: 45 days

Secondary

MeasureTime frame
Improvement in health statusTimepoint: 45 days

Countries

India

Contacts

Public ContactDr Vikash Kumar Gujral

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University, Karwar, Jodhpur, Rajasthan

rai.dinesh3007@gmail.com8619806829

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026